All In MedTech

Device Trial Radar · NCT07867808

Pulsed Electromagnetic Versus Hydrotherapy on Chronic Pelvic Pain

Effect of Pulsed Electromagnetic Field Versus Hydrotherapy on Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

300

Planned (sponsor's estimate)

Start

Jul 20, 2026

Primary completion

Oct 30, 2026

Study completion Nov 30, 2026

Sponsor

Lead sponsor
Horus UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 9, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Male only, from 42 years, up to 52 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Both interventions have demonstrated potential benefits in reducing pain severity and improving functional outcomes and quality of life in patients with chronic pelvic pain syndrome, supporting their investigation as therapeutic options in clinical research

Conditions

  • Chronic Pelvic Pain Syndrome

Interventions

  • pulsed electromagnetic fieldDevice

    Participants allocated to the experimental group will receive pulsed electromagnetic field therapy using a low-frequency PEMF device applied over the suprapubic and perineal regions. Participants will be positioned comfortably in a supine lying position during treatment. The electromagnetic field will be delivered at therapeutic frequencies and intensities according to the manufacturer's recommendations for pain management and soft tissue healing. Each treatment session will last approximately 20-30 minutes, administered three sessions per week for 12 weeks.

  • hydrotherapyDevice

    Participants allocated to the hydrotherapy group will undergo a supervised aquatic exercise program conducted in a therapeutic pool with warm water maintained at 32-34°C. Each session will last approximately 45-60 minutes, three times per week for 12 weeks. The intervention will include gentle warm-up exercises, pelvic mobility exercises, stretching, relaxation techniques, and low-to-moderate intensity aerobic and strengthening activities performed in water.

  • traditional physical therapy programOther

    The intervention will be administered by a licensed physiotherapist and will consist of pelvic floor muscle awareness training, relaxation exercises, diaphragmatic breathing, stretching exercises, and controlled pelvic floor muscle contractions. Treatment sessions will be conducted three times per week for 12 weeks, with each session lasting approximately 30-45 minutes. Participants will also be instructed to perform a structured home exercise program on non-treatment days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. chronic pelvic painTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Horus University in Egypt

    Amman, Jordan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.